Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BNY).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: Futures: FTSE (0.04%), DAX (0.30%), CAC40 (0.13%)

May 05 ,2026

  • Synopsis

    • European equity markets are set to open lower, whilst Asian equities weaker Tuesday. Hong Kong and Australia trading lower with Taiwan fluctuating . Japan, mainland China and South Korea offline for holidays and UK back online after bank Holiday.

    • Risk-off tone attributed to flare-up in Middle East tensions after US and Iran traded fire in Strait of Hormuz as US launched 'Project Freedom' to aid shipping through the waterway. UAE's Fujairah port and oil tankers were also hit, contributing to surge in crude oil. Developments underlined fragility of ceasefire with two sides still no closer to an agreement to end hostilities. Trump's vacillation between escalating conflict and pursuing agreement seen prolonging State of Hormuz status quo and leaving crude supply strained.

    • Also on today's agenda, on the political front, ECOFIN meeting, ECB's de Guindos, EU's Albuquerque and Fitto among the attendees. Meeting of the European Political Community, forum for political dialogue in Europe that includes 47 countries, Norway's PM Støre, EU's von der Leyen, Canada's PM Carney (guest) among the attendees. Italian PM Meloni due to visit Azerbaijan. Later in the day, Chancellor Merz hosts Portuguese PM Montenegro. A joint press conf is planned. Norway's PM Støre and minister of energy Aasland host meeting with business leaders topic "Security for the country: Jobs, value creation and stable deliveries of oil and gas to Europe". Nordic defense ministers' meeting (NORDEFCO) (through Wed) and Spain's President Sánchez host EU's Kos. EU's Jørgensen delivers speeches at the General Assembly of the Energy Efficiency Financing Coalition and at the Solar Power Summit 2026, delivers concluding remarks at a joint event with the European Parliament on housing. EU's Kadis participates in the MedFish4Ever Conf and EU's Roswall speaks at the Plastics Recycling Show Europe 2026 (PRSE) and at the event 'Circular Economy Act: Key Priorities' hosted by Business Europe. Economist hosts Space Economy Summit Europe (through Wed). Politico AI & Tech Week (through Thu).

    • In central banks, Norges Bank's Bache and NBIM's Tangen at Storting's Finance Committee hearing at 9:00CET on the Government Pension Fund Global annual report whilst Denmark central bank's Nødgaard speech at 9:10CET at the PSD3 & Open Banking conf. Climate, Nature and Price Stability Conf organised by ECB, Frankfurt School and CETEX sees introductory remarks from ECB's Lagarde at 14:30CET, ECB's Lane speech at 17:30CET. BOE's Woods, Fed's Barr fireside chat at 17:30BST at Magdalen College, Oxford and Bank of Italy's Panetta speech at the Italian Embassy in London. Annual AML Center Conf in partnership with Lithuania central bank, governor Šimkus welcome remarks at 9:10.

    • Macro data due today includes Switzerland Apr CPI and Spain Apr unemployment change.

    • A busy morning for earnings with Banks kicking off the sessions with HSBC Holdings (HSBA.LN), Banco de Sabadell, (SAB.SM), Raiffeisen Bank International (RBI.AV) and UniCredit (UNI.IM) reporting Q1 earnings. Out of the DACHs region, Fresenius Medical Care (FME.GR), Rheinmetall (RHM.GR), Geberit (GEBN.SW) and Hugo Boss (BOSS.GR) released Q1 earnings numbers. Elsewhere, Anheuser-Busch InBev (ABI.BB) issued Q1 figures. In Nordics, Elopak (ELO.NO), ISS A/S (ISS.DC) and International Petroleum Corp (IPCO.SS) are amongst others in the region to update investors with their latest numbers.

  • Politics/Macro/World News

    • Trump's threats give EU pause for thought ahead of US trade deal vote - FT

    • US to move forward with plans to hike EU car tariffs - Reuters

    • EU Commission spending on energy consultants jumps 400% over decade - FT

    • US strikes Iranian fast boats as Iran attacks UAE oil facility - BBC

  • Top company news

    • Earnings/updates

      • DAHCs

        • FME.GR (Fresenius Medical Care) -- reports Q1 EPS €0.43 vs consensus €0.40; FY26 outlook confirmed

        • RHM.GR (Rheinmetall) -- reports preliminary Q1 operating income €224M vs FactSet €253.5M [7 est, €200-298M]

        • ADV.GR (Adtran Networks) -- reports Q1 pro forma EBIT (€1.4M) vs year-ago (€4.8M)

        • SPG.GR (Springer Nature) -- reports Q1 Adjusted operating profit €106.7M vs FactSet €103.0M [1 est]; FY 2026 guidance reiterated

        • FRA.GR (Fraport) -- reports Q1 net income (€33.1M) vs consensus (€25.8M); confirms FY guidance

        • NOEJ.GR (Norma Group) -- reports Q1 adj EPS €0.03 vs year-ago (€0.27); FY26 outlook confirmed

        • GEBN.SW (Geberit) -- reports Q1 EPS CHF5.94 vs year-ago CHF5.69

        • WSU.GR (Washtec) -- reports Q1 EPS €0.17 vs year-ago €0.22

        • GAV.SW (Carlo Gavazzi Holding) -- reports preliminary FY net profit CHF1.8M vs year-ago CHF4.1M

        • BOSS.GR (Hugo Boss) -- reports Q1 EPS €0.24 vs consensus €0.20; FY26 outlook reaffirmed

        • YSN.GR (secunet Security Networks) -- reports Q1 EBIT (€4.0M) vs FactSet (€3.2M) [1 est]; confirms FY26 outlook

        • RBI.AV (Raiffeisen Bank International) -- reports Q1 net income €470M vs FactSet €445.8M [4 est, €248-616M]

      • Benelux

        • ABI.BB (Anheuser-Busch InBev) -- reports Q1 underlying EPS $0.97 vs consensus $0.89

      • France

        • ELIS.FP (Elis) -- reports Q1 revenue €1.18B vs FactSet €1.18B [2 est, €1.18-1.19B]

        • VCT.FP (Vicat) -- reports Q1 revenue €922M vs FactSet €895.0M [1 est]

        • RUI.FP (Rubis) -- reports Q1 revenue €1.79B, +6% vs year-ago €1.70B

        • BEN.FP (Beneteau) -- reports H1 revenue €169.5M, +30% vs year-ago €130.3M

      • Nordics

        • YUBICO.SS (Yubico) -- reports Q1 EPS SEK0.25 vs FactSet SEK0.27 [3 est, SEK0.16-0.44]

        • ELO.NO (Elopak) -- reports Q1 EPS €0.06 vs FactSet €0.06 [6 est, €0.04-0.09]

        • NOHO.FH (NoHo Partners) -- reports Q1 EPS €0.01 vs FactSet €0.04 [4 est, €0.02-0.07]

        • TRIFOR.DC (Trifork Holding) -- reports Q1 EBIT €4.7M vs FactSet €4.5M [4 est, €4-5.5M]

        • ACAST.SS (Acast) -- reports Q1 EPS SEK0.09 vs year-ago (SEK0.51)

        • PEXIP.NO (Pexip Holding) -- reports Q1 revenue $40.7M, +30% vs year-ago $31.4M

        • ISS.DC (ISS A/S) -- reports Q1 revenue DKK21.94B vs consensus DKK21.58B; FY26 outlook is unchanged

        • HANZA.SS (HANZA AB) -- reports Q1 EPS SEK2.15 ex-items vs FactSet SEK1.91 [2 est, SEK1.80-2.02]

        • SALT.B.SS (SaltX Technology Holding) -- reports Q1 EPS (SEK0.10) vs FactSet (SEK0.12)

        • BRAV.SS (Bravida Holding) -- reports Q1 EPS SEK1.17 vs FactSet SEK1.09 [6 est, SEK0.90-1.19]

        • DFDS.DC (DFDS) -- reports Q1 EBIT DKK33M vs FactSet DKK55M [2 est, DKK14-96M]

        • IPCO.SS (International Petroleum Corp) -- reports Q1 net income $12.8M vs FactSet $11.1M [6 est, ($0.1)-28.7M]; updates FY guidance

      • Southern Europe

        • SAB.SM (Banco de Sabadell) -- reports Q1 net income attributable including TSB €347M; reaffirms FY guidance

        • UCG.IM (UniCredit) -- reports Q1 net income €3.22B vs FactSet €2.72B [8 est, €2.56-2.90B]; upgrades FY26 net profit guide; FY28 and FY30 net profit ambitions reaffirmed

        • UNI.SM (Unicaja Banco)-- reports Q1 net income €161M vs FactSet €154.8M [12 est, €150-159M]

      • Others

        • HSBA.LN (HSBC Holdings) -- reports Q1 EPS $0.40 vs consensus $0.41

      • Also due to report today includes

        • Earnings:

          • Denmark: Novonesis (NSIS.B.DC), ALK-Abello (ALK.B.DC), NTG Nordic Transport Group (NTG.DC)

          • Finland: Kalmar (KALMAR.FH)

          • France: Viridien (VIRI.FP)

          • Germany: Infineon Technologies (IFX.GR), Covestro (1COV.GR), Schaeffler (SHA0.GR), Elmos Semiconductor (ELG.GR), Washtec (WSU.GR)

          • Italy: Leonardo (LDO.IM), Banco BPM (BAMI.IM), Italgas (IG.IM), Unicaja Banco (UNI.SM), Lottomatica Group (LTMC.IM), Credito Emiliano (CE.IM), Amplifon (AMP.IM)

          • Portugal: Corticeira Amorim SGPS (COR.PL)

          • Spain: Prosegur Compania de Seguridad (PSG.SM)

          • Sweden: Proact IT Group (PACT.SS), Medivir (MVIR.SS), Prevas (PREV.B.SS), Embellence Group (EMBELL.SS), Nordisk Bergteknik (NORB.B.SS), Xbrane Biopharma (XBRANE.SS), AlzeCure Pharma (ALZCUR.SS), Alligator Bioscience (ATORX.SS)

          • Switzerland: Logitech International (LOGN.SW)

          • UK: Air Astana (AIRA.LN)

        • Trading Update:

          • Benelux: Theon International (THEON.NA)

          • France: AXA (CS.FP), JCDecaux (DEC.FP), Figeac Aero (FGA.FP), Bonduelle (BON.FP), HERIGE (ALHRG.FP)

          • Nordics: Demant (DEMANT.DC), Remedy Entertainment (REMEDY.FH)

          • Sales: Volvo Car (VOLCAR.B.SS)

        • CMD/Events: Pandox (PNDX.B.SS)

    • M&A

      • MC.FP (LVMH Moet Hennessy Louis Vuitton) -- LVMH exploring sale of brands such as Marc Jacobs and stake in Fenty Beauty as it slims down amid lower demand - FT

      • NVRI (Enviri) -- shareholders approve sale of Clean Earth division to Veolia

      • SGSN.SW (SGS) -- acquires Keystone Bioanalytical; terms undisclosed

      • 1.HK (CK Hutchison Holdings) -- agrees to buyout of 49% stake in VodafoneThree for £4.30B (HK$45.58B) in cash

      • THEON.NA (Theon International) -- HEON enters into binding terms/ exclusivity agreement for the acquisition of MERIO; terms not disclosed

      • Keppel no longer in contest to acquire Plus ES - The Australian

    • Healthcare

      • SAN.FP (Sanofi) -- invests $294M to expand AI Center of Excellence in Toronto and accelerate innovation for patients

      • CYTK (Cytokinetics) -- to announce topline results from ACACIA-HCM ph3 trial of aficamten in non-obstructive hypertrophic Cardiomyopathy tomorrow, 5-May; webcast at 8:00ET

      • SN.LN (Smith & Nephew) -- SEC filing: SCHEDULE 13D/A (Filed by Cevian Capital II GP LTD)

      • TLX.AU (Telix Pharmaceuticals) -- reports new independent analysis of Phase 3 ZIRCON trial data published in European Urology

      • NANO.FP (Nanobiotix) -- announces protocol amendment to ongoing global Phase 3 head and neck cancer study

    • Other

      • DG.FP (VINCI SA) -- signs share purchase agreement with investment services provider as part of buyback program

      • VACN.SW (VAT Group) -- COO Thomas Berden to pursue opportunities outside company

      • GALP.PL (Galp Energia SGPS) -- announces approval of the unitisation agreements for the Berbigoo and Sururu accumulations, in the Brazilian Santos basin

      • TGS.NO (TGS-NOPEC Geophysical Co.) -- TGS announces new ~75-days multi-client 3D survey in the Norwegian North Sea

      • Italy Apr new passenger car registrations 155,210 units, +11.6% y/y; Lowers FY market growth forecast -- UNRAE

      • Spain Apr new passenger car registrations 106,862 units, +8.4% y/y - ANFAC

  • Key rating changes

    • Upgrades

      • ITRK.LN (Intertek Group) -- to outperform from sector perform at RBC Capital Markets

      • BVI.FP (Bureau Veritas) -- to sector perform from underperform at RBC Capital Markets

      • SGSN.SW (SGS) -- to sector perform from underperform at RBC Capital Markets

      • DOKA.SW (dormakaba Holding) -- to outperform from neutral at Oddo

      • ORA.FP (Orange) -- to buy from neutral at Goldman Sachs

      • SSAB.A.SS (SSAB) -- to overweight from equal-weight at Morgan Stanley

    • Downgrades

      • SCATC.NO (Scatec) -- to neutral from buy at Sparebank 1 Markets

      • XFAB.FP (X-FAB Silicon Foundries) -- to hold from buy at Berenberg

    • Initiations

      • BRBY.LN (Burberry Group) -- hold at Berenberg

      • ACE.IM (ACEA) -- outperform at Oddo

  • Data

    • Nikkei +0.00% to 59513.12

    • Hang Seng (1.27%) to 25765.71

    • Shanghai Composite +0.00% to 4112.16

    • S&P futures +13.0 vs prior close of 7230.3

    • €-$ (0.0005) or (0.04%) to 1.1685

    • $-¥ +0.03 or +0.02% to 157.28

    • €-¥ (0.08) or (0.04%) to 183.76

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE

    • BNY.com Terms of Use Privacy Cookie Notice Manage Cookies Disclaimer CUSIP Disclaimer

    • ©  2025 The Bank of New York Corporation. Depositary Receipt business and services are conducted through The Bank of New York.